Short answer · Medically reviewed summary · Last updated: 2023-07-13
Ross Syndrome is a rare disorder that affects the autonomic nervous system, specifically the sweat glands and blood vessels. It is characterized by a triad of symptoms including anhidrosis (the inability to sweat), areflexia (the absence of reflexes), and tonic pupils (fixed and dilated pupils). The prevalence of Ross Syndrome is not well-established due to its rarity and the lack of large-scale studies.
What is the prevalence of Ross Syndrome?
Prevalence of Ross Syndrome: how many people are affected worldwide, differences by sex and region, with sources.
Ross Syndrome is a rare disorder that affects the autonomic nervous system, specifically the sweat glands and blood vessels. It is characterized by a triad of symptoms including anhidrosis (the inability to sweat), areflexia (the absence of reflexes), and tonic pupils (fixed and dilated pupils).
The prevalence of Ross Syndrome is not well-established due to its rarity and the lack of large-scale studies. However, it is considered to be an extremely uncommon condition. The available literature suggests that Ross Syndrome affects both males and females, with a slight predominance in males. It typically manifests in early adulthood, between the ages of 20 and 40.
Due to its rarity and the overlap of symptoms with other conditions, Ross Syndrome is often misdiagnosed or underdiagnosed. This further complicates the estimation of its prevalence. It is important for healthcare professionals to be aware of this syndrome and consider it as a potential diagnosis in individuals presenting with the characteristic symptoms.
Further research and awareness are needed to better understand the prevalence and characteristics of Ross Syndrome, as well as to improve diagnostic accuracy and management strategies for affected individuals.
